Literature DB >> 16050893

Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Daniella A Zipkin1, Michael A Steinman.   

Abstract

OBJECTIVE: Medical school and residency are formative years in establishing patterns of prescribing. We aimed to review the literature regarding the extent of pharmaceutical industry contact with trainees, attitudes about these interactions, and effects on trainee prescribing behavior, with an emphasis on points of potential intervention and policy formation.
DESIGN: We searched MEDLINE from 1966 until May 2004 for English language articles. All original articles were included if the abstract reported content relevant to medical training and the pharmaceutical industry. Editorials, guidelines, and policy recommendations were excluded.
MEASUREMENTS AND MAIN RESULTS: Contact with pharmaceutical representatives was common among residents. The majority of trainees felt that the interactions were appropriate. A minority felt that their own prescribing could be influenced by contact or gifts, but were more likely to believe that others' prescribing could be influenced. Resident prescribing was associated with pharmaceutical representative visits and the availability of samples. A variety of policy and educational interventions appear to influence resident attitudes toward interactions with industry, although data on the long-term effects of these interventions are limited. Overall, residents reported insufficient training in this area.
CONCLUSIONS: The pharmaceutical industry has a significant presence during residency training, has gained the overall acceptance of trainees, and appears to influence prescribing behavior. Training programs can benefit from policies and curricula that teach residents about industry influence and ways in which to critically evaluate information that they are given. Recommendations for local and national approaches are discussed.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  2005        PMID: 16050893      PMCID: PMC1490177          DOI: 10.1111/j.1525-1497.2005.0134.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  55 in total

1.  Physicians and the pharmaceutical industry: is a gift ever just a gift?

Authors:  A Wazana
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

2.  Pharmaceutical branding of resident physicians.

Authors:  S K Sigworth; M D Nettleman; G M Cohen
Journal:  JAMA       Date:  2001-09-05       Impact factor: 56.272

3.  An innovative approach to educating medical students about pharmaceutical promotion.

Authors:  M S Wilkes; J R Hoffman
Journal:  Acad Med       Date:  2001-12       Impact factor: 6.893

4.  Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.

Authors:  M A Steinman; M G Shlipak; S J McPhee
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

5.  Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.

Authors:  B B McCormick; G Tomlinson; P Brill-Edwards; A S Detsky
Journal:  JAMA       Date:  2001 Oct 24-31       Impact factor: 56.272

6.  Definitions and competencies for practice-based learning and improvement.

Authors:  Stephen R Hayden; Susan Dufel; Richard Shih
Journal:  Acad Emerg Med       Date:  2002-11       Impact factor: 3.451

7.  High-tech stealth being used to sway doctor prescriptions.

Authors:  S G Stolberg; J Gerth
Journal:  N Y Times Web       Date:  2000-11-16

8.  Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.

Authors:  T L Schwartz; D J Kuhles; M Wade; P S Masand
Journal:  Ann Clin Psychiatry       Date:  2001-09       Impact factor: 1.567

9.  Benchmarks of support in internal medicine residency training programs.

Authors:  Susan D Wolfsthal; Brent W Beasley; Richard Kopelman; William Stickley; Timothy Gabryel; Marc J Kahn
Journal:  Acad Med       Date:  2002-01       Impact factor: 6.893

10.  Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.

Authors:  S Razack; L Arbour; R Hutcheon
Journal:  Ann R Coll Physicians Surg Can       Date:  1999-03
View more
  37 in total

1.  Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective.

Authors:  Johannes P Borde; Sarah Nussbaum; Stefanie Hauser; Philip Hehn; Johannes Hübner; Gabriela Sitaru; Sebastian Köller; Bruno Schweigert; Katja deWith; Winfried V Kern; Klaus Kaier
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

2.  Response to "Interactions between pharmaceutical representatives and doctors in training: a thematic review".

Authors:  Leana S Wen; Christopher McCoy
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

3.  Interactions of doctors with the pharmaceutical industry.

Authors:  M A Morgan; J Dana; G Loewenstein; S Zinberg; J Schulkin
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

Review 4.  Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.

Authors:  Hneine Brax; Racha Fadlallah; Lina Al-Khaled; Lara A Kahale; Hala Nas; Fadi El-Jardali; Elie A Akl
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

5.  Has the hunt for conflicts of interest gone too far? No.

Authors:  Kirby Lee
Journal:  BMJ       Date:  2008-03-01

6.  Gifts and corporate influence in doctor of pharmacy education.

Authors:  Peggy Piascik; Daphne Bernard; Suresh Madhavan; Todd D Sorensen; Steve C Stoner; Tom TenHoeve
Journal:  Am J Pharm Educ       Date:  2007-08-15       Impact factor: 2.047

7.  Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.

Authors:  Amie C O'Donoghue; Vanessa Boudewyns; Kathryn J Aikin; Emily Geisen; Kevin R Betts; Brian G Southwell
Journal:  J Health Commun       Date:  2015-07-15

8.  Drug samples in family medicine teaching units: a cross-sectional descriptive study: Part 1: drug sample management policies and the relationship between the pharmaceutical industry and residents in Quebec.

Authors:  Caroline Rhéaume; Michel Labrecque; Nadine Moisan; Jacky Rioux; Émilie Tardieux; Fatoumata Binta Diallo; Marie-Thérèse Lussier; Andréa Lessard; Roland Grad; Pierre Pluye
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

Review 9.  Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

Authors:  Geoffrey K Spurling; Peter R Mansfield; Brett D Montgomery; Joel Lexchin; Jenny Doust; Noordin Othman; Agnes I Vitry
Journal:  PLoS Med       Date:  2010-10-19       Impact factor: 11.069

10.  Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.

Authors:  Michael A Steinman; Dean Schillinger
Journal:  Am J Bioeth       Date:  2010-01       Impact factor: 11.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.